Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (BEIGF) Interest Expenses (2016)

BeOne Medicines (BEIGF) has disclosed Interest Expenses for 2 consecutive years, with $284000.0 as the latest value for Q3 2016.

  • Quarterly Interest Expenses fell 5.33% to $284000.0 in Q3 2016 from the year-ago period, while the trailing twelve-month figure was $284000.0 through Jun 2017, down 55.97% year-over-year, with the annual reading at $58.2 million for FY2025, 167.07% up from the prior year.
  • Interest Expenses for Q3 2016 was $284000.0 at BeOne Medicines, up from $141000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $300000.0 in Q3 2015, with the low at $141000.0 in Q2 2016.